Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

Issue 19 - Minutes of Proceedings - September 24, 2014

OTTAWA, Wednesday, September 24, 2014
(42)

[English]

The Standing Senate Committee on Social Affairs, Science and Technology met this day at 4:13 p.m., in room 2, Victoria Building, the chair, the Honourable Kelvin Kenneth Ogilvie, presiding.

Members of the committee present: The Honourable Senators Chaput, Eggleton, P.C., Enverga, Nancy Ruth, Ogilvie, Seidman, Seth and Stewart Olsen (8).

In attendance: Sonya Norris and Marlisa Tiedemann, Analysts, Parliamentary Information and Research Service.

Also in attendance: The official reporters of the Senate.

Pursuant to the order of reference adopted by the Senate on Thursday, September 18, 2014, the committee began its study of Bill C-17, An Act to amend the Food and Drugs Act.

WITNESSES:

Terence Young, Member of Parliament for Oakville and founder of Drug Safety Canada.

Patients Canada:

Alies Maybee, Patient Leader.

Psychiatric Medication Awareness Group:

Janet Currie, Representative

Best Medicines Coalition:

Christine Janus, Board Member

The chair made a statement and informed the committee that the clerk of the committee received a written declaration of a private interest made by the Honourable Pana Merchant, in relation to the committee's consideration of Bill C-17.

Terence Young made a statement and answered question.

At 4:40 p.m., the committee suspended.

At 4:45 p.m., the committee resumed.

The chair informed the committee that a written submission was received in one language only.

It was agreed that the document be distributed and that the translated version follow when received.

Ms. Maybee, Ms. Currie and Ms. Janus each made a statement and, together, answered questions.

At 5:44 p.m., the committee adjourned to the call of the chair.

ATTEST:

Josée Thérien

Acting Clerk of the Committee